| PE TTM | 62.54Industry PE 57.28 |
|---|---|
| Market Cap | ₹34,781.99 CrHealthcare Facilities |
| Promoter Holding | 33.0%Zero Pledge |
| RSI | 49.07Neutral Zone |
| Metric | Q2-27 | Q1-27 | Q2-26 |
|---|---|---|---|
| Revenue from Operations | 1,469 | 1,304 | 1,099 |
| Other Income | 23.6 | 22.2 | 19.7 |
| Total Income | 1,493 | 1,326 | 1,119 |
| Profit Before Tax | 295 | 213 | 200 |
| Exceptional Items | 0.0 | 0.0 | 16.0 |
| Net Profit | 219 | 157 | 158 |
| Operating Margin | 19.7% | 16.1% | 17.9% |
| Net Profit QoQ | +39.3% | ||
| Net Profit YoY | +38.3% | ||
| Adj. Profit QoQ | +41.9% | ||
| Adj. Profit YoY | +65.3% | ||
Key highlights
- Consolidated revenue from operations reached ₹1,469 crore, a 33.7% increase compared to Q2 FY26
- Net profit for Q2 FY27 rose to ₹219 crore, up from ₹157 crore in the previous quarter
- Operating margins improved to 19.7%, expanding from 16.1% in Q1 FY27
- Approved ₹997 crore budget for a new 500-bed multi-specialty hospital in Ghaziabad, Uttar Pradesh
- Existing operational capacity stood at 3,811 beds across seven key Indian cities as of September 2026
Operational Scale-up and Margin Improvement
Global Health Limited demonstrated significant operational leverage in the second quarter of FY27. Consolidated revenue from operations climbed to ₹1,469 crore, representing a 12.6% growth over the immediate preceding quarter. This revenue growth was accompanied by a sharp improvement in operating margins, which stood at 19.7% for Q2 FY27, up from 16.1% in Q1 FY27 and 17.9% in the year-ago period.
The bottom line reflected this efficiency, with net profit reaching ₹219 crore. The results were reviewed by statutory auditors Walker Chandiok & Co LLP, who issued an unmodified opinion, confirming the stability of the company’s standalone and consolidated financial statements for the half-year ended September 30, 2026.
Strategic Expansion in the Ghaziabad Micro-Market
- The Board approved a total project budget of ₹997 crore, which includes the cost of land and construction.
- A 500-bedded multi-specialty hospital will be built on a 10,560.36 sq. meter land parcel in Siddharth Vihar, Ghaziabad.
- The land purchase cost of ₹165.82 crore has already been committed following an allotment by the UP Housing & Development Board.
- Construction is slated to be funded through a mix of internal accruals and debt, with capacity added over the next 3-4 years.
- The Ghaziabad site is positioned to serve as a referral catchment for East Delhi and the broader western Uttar Pradesh belt.
Rationale for the New 500-Bed Facility
The proposed site at Siddharth Vihar offers a strategically positioned location for a large-scale integrated healthcare facility in one of the city’s fastest-developing micro markets. The project would enable the Company to address growing demand for advanced medical care while leveraging its established clinical expertise.
Comparative Performance and Market Standing
Medanta's performance in Q2 FY27 shows a consistent upward trend compared to previous fiscal cycles. The net profit of ₹219 crore marks a substantial increase from the ₹158.73 crore reported in the same quarter last year. Historically, the company has seen varying profit levels, such as ₹95.02 crore in Q3 FY26 and ₹143.99 crore in Q4 FY26, suggesting a strong seasonal rebound in the current half-year.
While the stock has seen a 1-year price change of -1.36%, its market capitalization remains robust at over ₹34,700 crore. The current P/E ratio of 62.54 indicates that the market continues to price the stock at a premium relative to the industry average of 57.28, reflecting its position as a high-growth performer in the healthcare sector.
| Date | Announcement | Amount |
|---|---|---|
| 30 Jul 2026 | Q1 FY27 Consolidated Net ProfitSource: icicidirect.com | ₹158.73 Cr |
| 14 May 2026 | Q4 FY26 Consolidated Net ProfitSource: hdfcsec.com | ₹143.99 Cr |
| 04 Feb 2026 | Q3 FY26 Consolidated Net ProfitSource: hdfcsec.com | ₹95.02 Cr |
| 07 Nov 2025 | Q2 FY26 Consolidated Net ProfitSource: earnings.thecore.in | ₹158.00 Cr |
| 07 Aug 2025 | Q1 FY26 Consolidated Net ProfitSource: torusdigital.com | ₹159.01 Cr |
| 15 May 2025 | Q4 FY25 Consolidated Net ProfitSource: earnings.thecore.in | ₹101.40 Cr |
What to watch next
- Commencement of phased construction for the 500-bed Ghaziabad hospital project in early 2027
- Operational integration and financial contribution from the recently executed Business Transfer Agreement for the Indore oncology hospital
- Expected announcement of Q3 FY27 financial results in February 2027
- Progress on the proposal to acquire additional FSI for the Ghaziabad project to enhance total capacity
“Ghaziabad presents a compelling healthcare investment opportunity, underpinned by a large and expanding population, accelerating urbanisation, sustained residential and commercial development, and strong connectivity with the Delhi-NCR region.”
| Share price | ₹1293.6 |
|---|---|
| Market capitalisation | ₹34,781.99 Cr |
| Revenue (annual) | ₹4,410.27 Cr |
| Net profit (annual) | ₹556.46 Cr |
| Revenue (latest quarter) | ₹1,304.05 Cr+12.51% vs previous quarter |
| Net profit (latest quarter) | ₹158.73 Cr+10.24% vs previous quarter |
| P/E (TTM) | 62.54×Sector 53.73× |
| Promoter holding | 33%0.00% QoQ |
| FII holding | 9.92%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Global Health Limited announcing consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. Market figures from a third-party data provider.
